Knowledge and practice regarding the German and the EASL-EASD-EASO NAFLD-guidelines among members of the German Obesity Society
Nonalcoholic fatty liver disease (NAFLD) is a pathogenetically complex and clinically heterogeneous disease resulting from a diverse interaction of environmental components and a genetic background. It is a systemic condition featuring metabolic, cardiovascular, and (both hepatic and extrahepatic) cancer risk [1,2]. NAFLD is not only a sequelae of diabetes mellitus, obesity, and the metabolic syndrome, but itself is a determinant for the future development of type 2 diabetes mellitus and the metabolic syndrome which has potentially relevant clinical implications for diagnosing, preventing, and treating these conditions [3,4].
Source: Digestive and Liver Disease - Category: Gastroenterology Authors: David Petroff, Matthias Bl üher, Johannes Wiegand Tags: Correspondence Source Type: research
More News: Cancer | Cancer & Oncology | Cardiology | Cardiovascular | Diabetes | Diabetes Mellitus | Diabetes Type 2 | Eating Disorders & Weight Management | Endocrinology | Environmental Health | Fatty Liver Disease (FLD) | Genetics | Germany Health | Heart | Liver | Liver Disease | Metabolic Syndrome | Non-alcoholic Fatty Liver Diseases (NAFLD) | Obesity | Urology & Nephrology